phase readout

NCT04432584: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

ACTIVE_NOT_RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Paroxysmal Nocturnal Hemoglobinuria

Data sources

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?